ELI LILLY bounce long This drug company sign agreement with another company for some kind of treatment for virus that is going global and also the daily and one and four hour chart is showing a nice trade set up for intra day long Long03:23by SirTraderUSAMar 14, 20204
LLY Sell the RallyMy dowsing method suggests LLY gets their FDA approval, and the stock will pop, but that in the longer term, this stock is going to breakdown; probably with the entire market. I'm getting that the resistance will be around that $145-46 zone, which would also be a test of the uptrend line from below. Good luck! NShortby JenRzUpdated Feb 26, 20201
US FDA approves only triple-combination tablet with Jardiance® fLLY: Eli Lilly and Company 2020-01-27 17:34:00 US FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetesNLongby RocketTickersJan 28, 20205
LLY IDEA Lots of signs saying bullish IMO. I would like to see how the market opens up before entering. The bullish engulfment under the 20 day moving average is a good sign. Looking back a few weeks you can see strong resistance when the 20 day hits the 50 day moving average. This may be a time to buy at a slight discount. I thik I would like to see a nice buy candle as confirmation this next week. Good luck out there!Nby ryanklein608Mar 18, 20190
LLY trade shortIf LLY breaks down from the yellow candle today and opens below their and holds on the 15min chart, I would short it.Nby kman3556Jan 25, 20206
ELI LILLY ShortTrying to break resistance. Overbought. Potential short side.NShortby Neo_1Jan 6, 20205
Golden Cross In Eli Lilly Entry level $133.35 = Target price $150.00 = Stop loss $130 Golden cross just completed. Stock on verge of breakout after building a fantastic base in 2019. Alert set for break above $132 Company profile Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. It operates through the following segments: Human Pharmaceutical Products and Animal Health Products. The Human Pharmaceutical products segment includes the discovery, development, manufacturing, marketing and sales of human pharmaceutical products worldwide in the following therapeutic areas: neuroscience, endocrinology, oncology, cardiovascular and other. The Animal health Products segment operating through the Elanco Animal Health division, develops, manufactures, and markets products for both food and companion animals. The Animal health products include Rumensin, Tylan, Posilac, Paylean and other products for livestock and poultry, as well as Trifexis, Comfortis, and other products for companion animals. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.NLongby BullishchartsDec 30, 201942
LLY Long at trend continuation zoneLooking for a pullback to this demand zone on LLYNLongby FlyingSeaHorseDec 19, 20195
LLY - DAILY CHARTHi, today we are going to talk about LLY and its current landscape. We can observe at this timeframe, a confluence of technical factors, that entail a setup which might drive this asset to a new movement. The details of our analysis are highlighted in the chart above. Want to know more about our trades and ideas? Join the Traders Heaven today. Thank you for reading and leave your comments if you like. To have access to our exclusive contents, and see more of our work, join the Traders Heaven today! Link Below. Disclaimer: All content of Golden Dragon has only educational and informational purposes, and never should be used or take it as financial adviceNby Igor-SilvaDec 6, 201932
[ALGO TRADE] LLY ShortNot enough in capital to buy the stock but would have placed positions as such. Let's see if it hits TPNShortby krismerfulOct 30, 20193
$LLY Nice bullish setup for short term target 115 Long doji green candle at bottom supported by 2 days run up targeting 115 .. for long term LLY intend to decline NLongby WinnerTrader99Updated Oct 28, 20193
ELI LILLY and Company -LLY- Long - Bulissh Divergence and TailBullish divergence on the weekly and on the daily I see a missing right shoulder bullish divergence. After this strong price recejection, I expect a move up at least to this projected target zone. From there on, it could move up even more, but the trade is here to find a nice exit and perhaps reenter, or partially stay in this trade. If the reversal looks real solid, I might stay in the trade and setup a trailing stoploss. Entry will be around 110, but I first will see how the market opens on monday. Entry: 110.20 Exit: 117-120 SL: 105 R/R: 1:1,4 up to 1:2,0NLongby Tornado_TradingOct 27, 20194
a "maybe" buy LLYthis one looks slightly sketchy but i'm ok with itNLongby NervaTechUpdated Sep 10, 20192
Perfect C&H Example Breakout is 1/2 cup depth for target. Exactly what happen. Nby Goose_TradingAug 6, 20190
LLY: Earnings Play. Current wave iv retracement is at Fib 38.2% which is typical for waves iv. A great ER could cause a gap and go. LLY is currently is a steeper meltup channel. A good ER will continue the meltup. A bad ER could cause a gap down to the lower channel and the Fibn 50% level. A horrible ER can cause it to drop far enough to meet the HnS target of $91 and the Fib 61.8 levelNLongby Will_WongUpdated Jul 30, 20193
lly fails at 200nice spot to get short against on back test of 200 here, staying patient as we could grind for a few days, but if the 50 crosses 200 strong short opNShortby YoungPearlsJun 19, 20193
LLY: One of the NYSE Volume Leaders. Wait for a wave (iv)pullback to $110 before going longNby Will_WongUpdated Jun 11, 20191
holding supportbroke through down trend and held horizontal support, looks like it wants to test higher near term , either 123, or backtest of up trend.NLongby YoungPearlsMay 18, 20190
LLY: Two peaks sell signal I think the stock has finished the 5th Elliott wave on the daily chart as there is an AO indicator divergence and Bill Williams` trading signal "Two peaks" for sell. Going short using levels that are marked on the chart.NShortby AlexStanilevychApr 2, 2019115